Cotellic

Cotellic (cobimetinib) is an oral medication used in combination with other treatments for certain types of cancer. This prescription drug is designed to target specific proteins involved in cancer cell growth.

Cotellic is primarily used in combination with other cancer therapies to treat advanced or metastatic melanoma. It works by inhibiting certain proteins that help cancer cells grow and divide. Patients typically use this medication as part of a broader treatment plan determined by their healthcare provider.

Common effects of Cotellinib may include fatigue, nausea, diarrhea, and skin reactions. Some users may also experience changes in blood pressure or liver function. It's important to monitor for any unusual symptoms and consult a healthcare professional if concerns arise.

Cotellic should be handled with care, as it is a potent medication. It is essential to follow the prescribed dosage and administration instructions provided by a healthcare professional. Patients should avoid pregnancy while taking this medication due to potential risks.

Cotellic may interact with other medications, including those that affect liver enzymes. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and certain supplements may also affect the efficacy of this drug.